Bids Are Invited For Acquisition Medicines Subgroup Blood And Hematopoietic Organs.

Pharmacological Group: Anti -Nemical, Active Principle: Folic Acid, Pharmaceutical Form: Compressed, Concentration / Dosage: 5, Unit: Mg, Volume: Not Applicable, Presentation: Not Applicable, Accessory: Not Applicable, Pharmacological Group: Antigoacles, Antagonists And Antiagregrant Platelets, Active Principle: Concentration / Dosage, 50, 50, 50 Unit: Mg / Ml, Volume: 5 Ml, Presentation: Ampoule, Pharmacological Group: Hydroelectrolytic Solutions And Balancing Brokerages, Active Principle: Sterile And Apirogenic Distilled Water, Pharmaceutical Form: Liquid, Concentration / Dosage: Not Applicable, Unable: Not Applicable, Volume: 1St Group, 10Ml, 10Ml, Group Pharmacological: Plasma And Plasma Substitute Expanders, Active Principle: Human Albumin, Concentration/Dosage: 20, Unit: %, Volume: 50 Ml, Introduction: Vial Or Bag, 04/04/2025, Pharmacological Group: Thrombolytic, Active Principle: Alteplase, Pharmaceutical Form: Po Lionfilo: Diluent 50Ml, Pharmacological Group: Nutrition And Hydroelectrolytic Replacement Parenteral, Active Principle: Sodium Bicarbonate, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 8.4%, Volume: 10 Ml, Active Principle: Sodium Bicarbonate, Concentration / Dosage: 8, 4, Volume: 250Ml, Active Principle: Carboximosis Ferrica (Equivalent To 500Mg Of Iron Iii), Concentration/Dosage: 50 Mg, Form Supply: Unit, Pharmacological Group: Osse/Vitamin/Mineral Supplements Regulators, Active Principle: Cyanocobalamin, Concentration/Dosage: 5,000, Unit: Mcg, Volume: 2 Ml, Accessory: N/A, Pharmacological Group: Vasodilators And Sclerosing, Active Principle: Cilostazole, Active Principle: Clopidogrel, Concentration / Dosage: 75 Mg, Active Principle: Potassium Chloride 10%, Concentration / Dosage: 0, 1, Unit: G / Ml, Active Principle: Sodium Chloride Physiological Solution, Pharmaceutable Form: Injectable, 9, Active Principle Of Sterile Solution And Apirogenic, Presentation: Closed System, Volume: 100Ml, Volume: 500Ml, Active Principle: Sodium Chloride 20%, Concentration / Dosage: 200, Pharmacological Group: Coagulation And Related Factors, Active Principle: Protrombinic Complex (Factors Ii, Vii, Ix And X Of Coagulation), Concentration / Dosage: 500, Ui, N / A, Accessory: Diluent 20 Ml, Active Principle: Dabigatran Etexilate, Pharmaceutical Form: Capsule, Concentration / Dosage: 150, Presentation: N / A, Active Principle: Eltrombopag Olamina, Concentration / Dosage: 25, Active Principle: Enoxaparin, Volume: 0, 2Ml, Presentation: Completed Syringe), Concentration / Dosage: 40, 4Ml, Concentration / Dosage: 60, 6Ml, Pharmacological Group: Stimulants And Inhibitors, Active Principle: Human Erythropoetin, Concentration / Dosage: 10,000, Active Principle: Human Erythropietin, Concentration / Dosage: 4.000, Ui / Ml, Volume: 1Ml, Active Principle (Vitamin K1), Concentration / Dosage: 10, Active Principle: Glyceophosphate Sodium, Concentration / Dosage: 216, Volume: 20 Ml, Active Principle: Glucose Hypertonic Solution, Active Principle: Corresponds To Glucose 25% - 10Ml, 25, Active Principle: Glucose, Concentration / Dosage: 5%, Presentation: Jokes: Glucose And Sterile Apirogenic, Active Principle: Sodica Heparin, Concentration / Dosage: 5000, Presentation: Ampolo Bottle, 25Ml, Ativ Principle